NEW YORK, March 23, 2018 -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Seamus Fernandez will join the firm in June as a Senior Analyst and Senior Managing Director in a planned expansion of the firm’s Healthcare Research team. He will focus on companies in the pharmaceuticals industry globally and coordinate the firm’s research coverage of therapeutics.
Mr. Fernandez joins Guggenheim from LEERINK Partners, where he spent more than 10 years and served as a Managing Director covering major pharmaceutical and biotechnology companies, as well as specialty pharmaceuticals. Previous to joining LEERINK in 2006, he was a member of the Pharmaceuticals team at Cowen and Company’s Research Division. Mr. Fernandez began his career as a Research Associate at the University of Pennsylvania’s Department of Neurosurgery.
“We are excited for Seamus to join our Healthcare Research team,” said Stefano Natella, Director of Equity Research. “His deep industry knowledge, his ability to focus on the long-term issues driving this sector, and his differentiated approach to research will be key assets for our expanding research department. We look forward to his continued success at Guggenheim.”
Mr. Fernandez received his B.A. in Chemistry from Williams College.
About Guggenheim Securities
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, Los Angeles, San Francisco, and Houston. For more information, please contact us at [email protected] or 212.518.9200.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $305 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,300 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
1Assets under management are as of 12.31.2017 and include consulting services for clients whose assets are valued at approximately $66bn.
Media Contact
Ellen Cunningham
Guggenheim Partners
212.518.9578
[email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



